These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8713775)

  • 41. Use of porcine factor VIII in the treatment of patients with acquired hemophilia.
    Morrison AE; Ludlam CA; Kessler C
    Blood; 1993 Mar; 81(6):1513-20. PubMed ID: 8453098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of porcine factor VIII in Japan.
    Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
    [No Abstract]   [Full Text] [Related]  

  • 43. Porcine factor VIII: current status and future developments.
    Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():24-7; discussion 28-32. PubMed ID: 11882080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of porcine factor VIII in France.
    Negrier C
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):29-32. PubMed ID: 7939770
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial: Home therapy for haemophilia.
    Br Med J; 1975 Feb; 1(5955):417. PubMed ID: 1115959
    [No Abstract]   [Full Text] [Related]  

  • 46. Factor VIIIc inhibitors: an automated assay.
    Luddington R; Jennings I
    Med Lab Sci; 1992 Jun; 49(2):135-7. PubMed ID: 1487978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

  • 48. Highly purified porcine factor VIII in haemophilia A with inhibitors to factor VIII.
    Mayne EE; Madden M; Crothers IS; Ingles T
    Br Med J (Clin Res Ed); 1981 Jan; 282(6260):318. PubMed ID: 6780009
    [No Abstract]   [Full Text] [Related]  

  • 49. Porcine factor VIIIC in the management of patients with factor VIII inhibitors.
    Hay CR; Bolton-Maggs P
    Transfus Med Rev; 1991 Oct; 5(4):293-9. PubMed ID: 1802286
    [No Abstract]   [Full Text] [Related]  

  • 50. Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience.
    DiMichele DM; Gorman PO; Kasper CK; Mannucci PM; Santagostino E; Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():9-12; discussion 28-32. PubMed ID: 11882076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemophilia A home therapy in the United Kingdom 1975-6.
    Jones P; Fearns M; Forbes C; Stuart J
    Br Med J; 1978 Jun; 1(6125):1447-50. PubMed ID: 647330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Porcine factor VIII therapy in patients with factor VIII inhibitors.
    Hay C; Lozier JN
    Adv Exp Med Biol; 1995; 386():143-51. PubMed ID: 8851022
    [No Abstract]   [Full Text] [Related]  

  • 53. Viral pharmacovigilance study of haemophiliacs receiving porcine factor VIII.
    Giangrande PL; Kessler CM; Jenkins CE; Weatherill PJ; Webb PD
    Haemophilia; 2002 Nov; 8(6):798-801. PubMed ID: 12410650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors.
    Bona RD; Riberio M; Klatsky AU; Panek S; Magnifico M; Rickles FR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):32-5. PubMed ID: 8480196
    [No Abstract]   [Full Text] [Related]  

  • 55. Acquired factor VIII inhibitor associated with multiple sclerosis, successfully treated with porcine factor VIII.
    Hoyle C; Ludlam CA
    Thromb Haemost; 1987 Apr; 57(2):233. PubMed ID: 3110998
    [No Abstract]   [Full Text] [Related]  

  • 56. The prophylactic use of porcine factor VIII.
    Hilgartner MW
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):39-40. PubMed ID: 7939773
    [No Abstract]   [Full Text] [Related]  

  • 57. Factor VIII international units and reference materials.
    Bangham DR; Brozović M
    Thromb Diath Haemorrh; 1974 Mar; 31(1):3-11. PubMed ID: 4836134
    [No Abstract]   [Full Text] [Related]  

  • 58. The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIII.
    Hultin MB; Hennessey J
    Thromb Res; 1989 Jul; 55(1):51-6. PubMed ID: 2506662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Projected estimation of factor VIII requirements for home treatment based on a pilot study of two haemophilic patients.
    Davies SH
    Scand J Haematol Suppl; 1977; 30():87-9. PubMed ID: 267310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous infusion of recombinant porcine factor VIII for neurosurgical management of intracranial haemorrhage in a patient with severe haemophilia A with factor VIII inhibitor.
    Ruan GJ; Mao JJ; Sytsma TT; Akogyeram II; Wang Y; Ashrani AA; Pruthi RK
    Haemophilia; 2020 May; 26(3):e141-e144. PubMed ID: 32180301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.